Limitations, agreements, and source contact

Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus · Source last updated 2019-07-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restriction Type

LTE60

restrictive Agreement

true

point Of Contact

email

kurasa@nrgoncology.org

organization

NRG Oncology Statistics and Data Management Center - Buffalo

phone

716-845-7733

title

Angela M. Kuras, Associate Director of Data Management

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice